OXYLONE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Oxylone, and what generic alternatives are available?
Oxylone is a drug marketed by Pharmacia And Upjohn and is included in one NDA.
The generic ingredient in OXYLONE is fluorometholone. There are five drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the fluorometholone profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Oxylone
A generic version of OXYLONE was approved as fluorometholone by AMNEAL on January 9th, 2024.
Summary for OXYLONE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 67 |
Patent Applications: | 5,237 |
Formulation / Manufacturing: | see details |
DailyMed Link: | OXYLONE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for OXYLONE
US Patents and Regulatory Information for OXYLONE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pharmacia And Upjohn | OXYLONE | fluorometholone | CREAM;TOPICAL | 011748-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |